Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca


Journal

Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164

Informations de publication

Date de publication:
08 2020
Historique:
received: 19 02 2020
revised: 07 05 2020
accepted: 09 05 2020
pubmed: 3 6 2020
medline: 13 10 2021
entrez: 3 6 2020
Statut: ppublish

Résumé

Systemic lupus erythematosus (SLE) is an autoimmune multisystem disease featured by an increased cardiovascular risk that may lead to premature patient's death. It has been demonstrated that SLE patients suffer from early onset endothelial dysfunction which is due to the impairment of endogenous vascular repair mechanisms. Vascular integrity and homeostasis are maintained by endothelial progenitor cells (EPCs), which are mobilized in response to endothelial injury to replace damaged endothelial cells. Two main EPCs subpopulations exist in peripheral blood: endothelial colony forming cells (ECFCs), which represent truly endothelial precursors and can physically engraft within neovessels, and myeloid angiogenic cells (MACs), which sustain angiogenesis in a paracrine manner. Emerging evidence indicates that ECFCs/MACs are down-regulated and display compromised angiogenic activity in SLE, thereby contributing to the pathogenesis of this disease. Intracellular calcium (Ca

Identifiants

pubmed: 32482487
pii: S0896-8411(20)30104-9
doi: 10.1016/j.jaut.2020.102486
pii:
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102486

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Klara Komici (K)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.

Pawan Faris (P)

Laboratory of General Physiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Forlanini 6, 27100, Pavia, Italy.

Sharon Negri (S)

Laboratory of General Physiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Forlanini 6, 27100, Pavia, Italy.

Vittorio Rosti (V)

IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

Mario García-Carrasco (M)

Immunology and Rheumatology Department, Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico; Systemic Autoimmune Diseases Research Unit, Hospital de Especialidades, UMAE, Instituto Mexicano del Seguro Social, Puebla, Puebla, Mexico.

Claudia Mendoza-Pinto (C)

Immunology and Rheumatology Department, Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico; Systemic Autoimmune Diseases Research Unit, Hospital de Especialidades, UMAE, Instituto Mexicano del Seguro Social, Puebla, Puebla, Mexico.

Roberto Berra-Romani (R)

Department of Biomedicine, Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.

Ricard Cervera (R)

Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia, Spain.

Germano Guerra (G)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.

Francesco Moccia (F)

Laboratory of General Physiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, via Forlanini 6, 27100, Pavia, Italy. Electronic address: francesco.moccia@unipv.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH